Supply of Activated Charcoal Suspension (Medical Grade)

The contract entails the procurement and delivery of 4,000 units of medical-grade activated charcoal suspension specifically designed for emergency clinical use, adhering to stringent regulatory standards including FDA guidelines, current Good Manufacturing Practices (cGMP), and Defense Logistics Agency specifications. The product must meet exacting quality and safety benchmarks to ensure suitability for urgent healthcare applications, with all manufacturing and packaging processes compliant with federal pharmaceutical regulations. The subcontract is issued under the NAICS code 325412, indicating classification within pharmaceutical and medicinal product manufacturing, and is managed by the Department of Defense through the Defense Logistics Agency. Delivery is required to fulfill a critical operational need, though the precise location of performance is not specified. The contract, posted on June 26, 2026, carries the identification details SPE2DX25D9822 and SPE2D226F2879, and is accessible via the DIBBS portal. No set-aside provisions apply, and there is no designated point of contact listed, suggesting the procurement is governed by established DLA protocols with full accountability to federal supply chain standards. All units must be supplied in ready-to-use form, properly labeled, and accompanied by necessary documentation to verify compliance at time of receipt.